miR-185 and its anti-miR as a biomarker and therapeutic target for oral cancer

Oral Oncol. 2022 Jun:129:105873. doi: 10.1016/j.oraloncology.2022.105873. Epub 2022 Apr 22.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antagomirs
  • Biomarkers
  • Humans
  • MicroRNAs* / genetics
  • Mouth Neoplasms* / genetics
  • Mouth Neoplasms* / therapy

Substances

  • Antagomirs
  • Biomarkers
  • MIRN185 microRNA, human
  • MicroRNAs